Conference PaperPDF Available

Knowing ketamine users: Results from an online investigation

Authors:
  • Asociación Bienestar y Desarrollo

Abstract

Ketamine use has spread in Spain in recent years. In order to inform harm reduction projects, an online research was carried out. Among other variables, sources of information, topics of interest for ketamine users, harms experienced, risk behaviours and harm reduction behaviours were researched in a sample of 392 ketamine users. Ketamine users tended to consider themselves as moderately or well informed about ketamine, and their main sources of information were friends and websites. Health professionals and drug professionals were not relevant sources of information for ketamine users. They engaged in several risk behaviours and the use of harm reduction behaviours has to be improved in order to minimize harms. These issues must be a priority for harm reduction organizations who work with ketamine users.
T a l k | 122
N I G H T S 2 0 1 3
Knowing ketamine users: Results from an online investigation
Claudio Vidal Giné1, Jose López Guerrero1, Estrella Villalba Ruíz1
1
Energy Control - Asociación
Bienestar y Desarrollo (ABD), SP
ABSTRACT
Ketamine use has spread in Spain in recent years. In order to inform harm reduction projects, an online
research was carried out. Among other variables, sources of information, topics of interest for ketamine
users, harms experienced, risk behaviours and harm reduction behaviours were researched in a sample of
392 ketamine users. Ketamine users tended to consider themselves as moderately or well informed about
ketamine, and their main sources of information were friends and websites. Health professionals and drug
professionals were not relevant sources of information for ketamine users. They engaged in several risk
behaviours and the use of harm reduction behaviours has to be improved in order to minimize harms. These
issues must be a priority for harm reduction organizations who work with ketamine users.
CORRESPONDING AUTHOR
Name: Claudio Vidal Giné
E-mail: claudiovidal@energycontrol.org
1. Introduction
There is a growing perception in some
Spanish regions that recreational ketamine
use has spread in recent years, although the
real extension of its use remains unknown.
Maybe due to this recent spread, we are
lacking sufficient information to implement
harm reduction initiatives that surely and
effectively meet ketamine users’ realities and
needs.
Ketamine users are an under-researched
and hard-to-reach population, and only in
recent times has ketamine use become a
topic of interest for researchers, mainly due
to urinary symptoms in some users. In fact,
only a few publications were identified by us
in relation to recreational ketamine users
(e.g., Copeland and Dillon, 2005; Corazza,
Assi and Schifano, 2013; Dillon, Copeland
and Jansen, 2003; Jansen, 2000; Kalsi, Wood
and Dargan, 2011; Raynaud-Maurupt, Bello,
Akoka and Toufik, 2007) and only one was
published in Spain (Barriuso and Markez,
2004).
Some harm reduction strategies have been
implemented in recent years. Of those, the
majority were informational strategies
directed to inform ketamine users about
related risks and harm reduction behaviours.
For this reason, it’s important to know if
these strategies are well-adjusted or matched
to ketamine users’ needs and realities. In this
sense, to know what kind of sources of
information (and their credibility) ketamine
users employ, what kinds of information they
want to receive, what harms they are
experiencing, in what risk behaviours they
engage, or whether they practice or not
certain harm reduction behaviours, is crucial
in order to plan and implement actions
directed to this population.
Our research seeks to fill this gap in our
knowledge and understanding of ketamine
users and provide useful information that can
be used by harm reduction projects.
2. Method
According to previous research and the
areas of interest set by the research team, an
online questionnaire covering several issues
was developed. Along with sociodemographic
data, the questionnaire asked for: (1) degree
to which ketamine users considered
themselves informed about ketamine, (2)
sources of information used (friends,
websites, specialized internet forums, drug-
related professionals, health professionals,
books or magazines, media, non-
governmental organizations, and dealers) and
(3) degree of credibility for each source, (4)
T a l k | 123
N I G H T S 2 0 1 3
type of information they would like to be
informed about, (5) risk perception of drugs
used in the last year, (6) risk perception of
several risk behaviours (like injecting
ketamine or sharing straws), (7) how
frequently they engaged in risky behaviours,
(8) if they had ever experienced certain
harms, and (9) how frequently they practiced
certain harm reduction behaviours (See
questionnaire at:
http://ketamina.energycontrol.org).
Several notices were posted on the Energy
Control website, Facebook Fan page and
Twitter and shared with other harm
reduction organizations inviting people who
had used ketamine at least once in the last
year to enter
http://ketamina.energycontrol.org and fill an
anonymous questionnaire about ketamine
use.
For each variable, descriptive statistics were
calculated and, depending on the type of
variable, chi-square tests or mean
comparison tests were performed in order to
investigate gender differences. All data
analysis was performed with SPSS 15.0
statistical package.
3. Results
Between February 23 and June 21, 392
ketamine users (261 male and 131 female)
entered and completed the questionnaire.
Mean age was 26.1 for men and 25.7 for
women.
In general, ketamine users considered
themselves as moderately or well informed
about ketamine. Among their sources of
information, friends and websites were the
most employed, and their credibility was also
high. Disappointingly, health or drug-related
professionals were less used than dealers,
for example, and their credibility was also
lower. In relation to what type of
information ketamine users would like to
receive, information about ketamine
pharmacology and the risks associated with
its use were the main topics of interest for
them.
Ketamine users perceived that some drugs
and behaviours were risky. In general, all
substances were rated with a mean score
ranging between 2.3 (magic mushrooms) and
3.7 (mephedrone) on a 5-point scale. On the
other hand, risk perception for risk
behaviours ranged between 2.6 (mix
ketamine with cannabis) and 4.5 (inject
ketamine and share injection equipment) on
a 5-point scale.
Nearly 60% of the sample had experienced
memory problems and confusion and 34% of
the sample suffered from cystitis, slightly
more women (36.6%) than men (33%),
although this difference was not statistically
significant. The prevalence of other problems
was: changes in mood or behaviour (49.2%),
falls (40.1%), sleep problems (39.8%),
flashbacks (25.8%), and stomach pains (25%).
There were some risk behaviours prevalent
among ketamine users: mixing ketamine
with other drugs (83.4%), taking more
ketamine than was planned (82.7%), sharing
straws (68.9%), being a passenger in a
vehicle driven by a person who was under
the effects of ketamine (62.5%), and driving
under the effects of ketamine (30.1%). The
prevalence of injection was 6.9%. No gender
differences were identified except for driving
under the effects of ketamine that was more
prevalent among men (36%) than among
women (18.3%). In both men and women,
frequency in which they engaged in these
behaviours was variable, although a distinct
group engaged in them between
“sometimes” and “seldom”.
Finally, the percentage of ketamine users
who always engaged in the harm reduction
behaviours mentioned in the questionnaire
was as follows: space out the occasions you
take ketamine, 37.2%; space out doses, 27%;
setting a limit in the quantity of ketamine you
will take, 18.6%; avoid mixing ketamine with
other drugs, 8.7%; testing ketamine before
taking it, 7.4%; and agree that someone in
the group will not take ketamine, 3.8%. No
gender differences were observed.
4. Discussion
Ketamine users are an under-researched
and a hard-to-reach population. For this
reason, it’s important to develop innovative
T a l k | 124
N I G H T S 2 0 1 3
methods in order to obtain information
about them that can be useful for harm
reduction organizations. In this sense, online
research carried out by these organizations
can be an excellent tool due to their
proximity to drug users, especially through
the Internet, and their credibility.
Several themes emerged from the data.
First of all, it’s crucial to improve credibility
and use of health and drug professionals,
who can be extremely useful when problems
are experienced. On the other hand, it’s
important that harm reduction organizations
become aware of the possibilities that the
Internet offers them when developing
informational strategies.
Although ketamine users perceived the
risks associated to some drugs or to some
risk behaviours, they frequently engaged in
some behaviours that posed a risk to them.
It’s necessary to develop strategies
specifically addressed to the reduction of
these behaviours. Similarly, it’s necessary to
develop new strategies in order to improve
ketamine users’ adherence to harm
reduction behaviours because, although
many of them practised the majority of harm
reduction behaviours mentioned in the
questionnaire, the frequency in which they
did them was variable and the number of
ketamine users who “always” did them was
low.
Online questionnaires allow us to obtain
information quickly and at less cost than
other methods on drug use patterns and
other areas of interest for harm reduction
organizations. These organizations are in
direct contact with drug users and can easily
incorporate such methodologies into their
work. This will get harm reduction strategies
more tailored to the needs and realities of
drug users.
5. References
Barriuso, M., & Markez, I. (2004). El uso de
ketamina en el País Vasco: de fármaco
anestésico a droga de fiesta. Vitoria-
Gasteiz: Servicio Central de Publicaciones
del Gobierno Vasco.
Copeland, J., & Dillon, P. (2005). The health
and psycho-social consequences of
ketamine use. International Journal of
Drug Policy, 16, 122-131.
Corazza, O., Assi, S., & Schifano, F. (2013).
From “Special K” to “Special M”: The
evolution of the recreational use of
ketamine and methoxetamine. CNS
Neuroscience & Therapeutics, 19, 454-
460.
Dillon, P., Copeland, J., & Jansen, K. (2003).
Patterns of use and harms associated
with non-medical ketamine use. Drug and
Alcohol Dependence, 69, 23-28.
Jansen, K. (2000). A review of the nonmedical
use of ketamine: use, users, and
consequences. Journal of Psychoactive
Drugs, 32, 419-433.
Kalsi, S.S., Wood, D.M., & Dargan, P.L. (2011).
The epidemiology and patterns of acute
and chronic toxicity associated with
recreational ketamine use. Emerging
Health Threats Journal, 4:7107. DOI:
10.3402/ehtj.v4i0.7107.
Raynaud-Maurupt, C., Bello, P., Akoka, S., &
Toufik, A. (2007). Characteristics and
behaviors of ketamine users in France in
2003. Journal of Psychoactive Drugs, 39,
1-11).
ResearchGate has not been able to resolve any citations for this publication.
Article
Full-text available
Ketamine was originally synthesised for use as a dissociative anaesthetic, and it remains widely used legitimately for this indication. However, there is increasing evidence of non-medical recreational use of ketamine, particularly in individuals who frequent the night-time economy. The population-level and sub-population (clubbers) prevalence of recreational use of ketamine is not known but is likely to be similar, or slightly lower than, that of other recreational drugs such as cocaine, MDMA, and amphetamine. The predominant features of acute toxicity associated with the recreational use of ketamine are neuro-behavioural abnormalities such as agitation, hallucinations, anxiety, and psychosis. Secondary to these, individuals put themselves at greater risk of physical harm/trauma. Cardiovascular features (hypertension and tachycardia) occur less frequently and the risk of death from recreational use is low and is predominately due to the physical harm/trauma. Long-term recreational use of ketamine can be associated with the development of psychological dependence and tolerance. There are reports of gastro-intestinal toxicity, particularly abdominal pain and abnormal liver function tests, and of neuropsychiatric disorders, typically a schizophrenia-like syndrome, in long-term users. Finally, there are increasing reports of urological disorders, particularly haemorrhagic cystitis, associated with long-term use. The management of these problems associated with the long-term use of ketamine is largely supportive and abstinence from ongoing exposure to ketamine. In this review we will collate the available information on the epidemiology of recreational use of ketamine and describe the patterns of acute and chronic toxicity associated with its recreational use and the management of this toxicity.
Book
Full-text available
La ketamina, fármaco con propiedades anestésicas, amnésicas y analgésicas ha visto crecer su uso recreativo entre adolescentes en los países desarrollados, de modo minoritario pero con una peligrosidad potencial para los usuarios por lo cual es conveniente actualizar los conocimientos sobre esta sustancia.
Article
Full-text available
The increase in recreational use of ketamine in France led to the carrying out of a survey aimed at depicting the sociological profiles of French ketamine users, their addictive behaviors, and the characteristics relevant to the use of the substance. This survey is based upon the analysis of 250 questionnaires, 24 semi-directive interviews, and two focus groups. Data was collected between July 2002 and June 2003 among individuals who had used ketamine at least once since January 1, 2001. The respondents were mostly males with a polydrug addiction, aged about 24, with little post-secondary education and no steady job. Ketamine was generally the last substance experimented with throughout their lifetime, as of the age of 22. The article reviews the frequency of ketamine use observed in the population surveyed, as well as the routes of administration, the quantities used, the circumstances of use, the sought-after effects and those experienced, and the risks perceived by the users themselves. The data collected provides working facts to allow for the development and implementation of policies for preventing the use and abuse of ketamine among vulnerable populations.
Article
Ketamine is a non-competitive NMDA receptor antagonist that acts as a dissociative anaesthetic with analgesic and amnestic properties. Ketamine has broad areas of application and is a rapidly acting, relatively safe analgesic and anaesthetic agent, particularly for children and is widely used in veterinary practice. Ketamine can induce schizophrenic-like symptoms in healthy adults and schizophrenic patients. It has a wide margin of safety and there are very few cases of pure ketamine overdose recorded, with the majority of deaths due to the dangerous activities or contexts of its use. Information on ketamine is not routinely collected in population surveys and morbidity and mortality data collections. Levels of use in the general population, however, appear to be very low with higher levels in groups with access to the drug, medical and veterinarian professionals, and party drug users. There are a number of potential ketamine effects that may be seen as adverse or harmful, with growing evidence of the physical and psychological symptoms of ketamine dependence among recreational ketamine users. A withdrawal syndrome, including psychotic features, is beginning to be described. The use of ketamine with other neurotoxic drugs, such as alcohol, should be avoided. Increased rates of high risk sexual and injecting behaviours in association with ketamine use, however, have been reported by gay men and marginalised youth in the US. In conclusion, ketamine does not appear to currently pose a significant public health risk, however, at the individual level the usual harm minimisation strategies should be observed.
Article
AIMS: To review the recreational use of ketamine ("Special K"; KET) and explore the recent diffusion of its new derivative methoxetamine ("Special M"; MXE). METHODS: The literature search on the nonclinical/recreational use of KET and MXE was carried out in a range of medical databases. Considering the limitations of peer-reviewed information, data were integrated with a qualitative assessment of a range of websites, drug fora, and other online resources including e-newsgroups, chat rooms, mailing lists, e-newsletters, and bulletin boards. RESULTS: The recreational use of KET has started since its discovery in 1962. This was due to its rapid onset, short duration of action, and peculiar psychotropic effects ("K-hole"). The latter effect ranges from confusion to dissociation and depersonalization (near-death experience). However, KET abuse is often associated with physical and psychological side effects, of which the worst is urological/bladder toxicity. Recently, MXE has emerged as a legal and "bladder-friendly" KET alternative. MXE presents with the same dissociative effect of KET, but with slower onset and longer duration of action. However, MXE seems to be associated with worse side effects than KET, ranging from mood disturbances/suicidal attempts to acute cerebellar toxicity. CONCLUSIONS: After 50 years of its discovery, KET has led to the emergence of MXE. However, this latter derivative does not appear to be a safer alternative to KET itself.
Article
Ketamine is a dissociative anesthetic with an accepted place in human medicine. Ketamine also has psychedelic properties, and there has been a recent increase in nonmedical use linked with the growth of the "dance culture." This has attracted little comment in the formal literature but has been the subject of many reports in the media. Myths and misunderstandings are common. The psychedelic properties of ketamine have also led to its use as an adjunct to psychotherapy. This review is intended as a resource for the wide range of persons now requesting accurate information about the nonmedical use of ketamine. It accepts the current necessity of sometimes referring to anecdotal reports while seeking to encourage an increase in formal research. The review includes the history of ketamine, its growing role as a "dance drug," the sought-after effects (including the near-death experience) for which it is taken in a nonmedical context, how these are produced, common mental and physical adverse effects, and the ketamine model of schizophrenia.
Article
To (1) identify current patterns of non-medical ketamine use; and (2) identify potential harms associated with non-medical ketamine use. Cross sectional survey of lifetime ketamine users. Semi-structured interviews took place in public and private settings in Sydney Australia. One Hundred ketamine users. Self-reported experiences with and attitudes towards ketamine use. Ketamine appeared to be added to an already extensive drug use repertoire of a well-educated and informed sample. Many users reported regularly experiencing effects such as an inability to speak, blurred vision, lack of co-ordination and increased body temperature, which resulted in some either reducing their dose or stopping use. Many users had experienced significant negative effects, such that some had either reduced their dose or stopped use altogether and expressed concerns over some others. This study reinforces the need to develop harm minimisation campaigns that match the experiences and attitudes of their target group through careful needs assessment and appropriate evaluation.